Pharmacokinetic Evaluation of Single-dose Rosuvastatin 10 mg When Co-administered With Steady-state Tipranavir 500 mg/Ritonavir 200 mg TPV/r) B.I.D. in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Rosuvastatin (Primary) ; Ritonavir; Tipranavir
- Indications Atherosclerosis; Cardiovascular disorders; HIV infections; Hypercholesterolaemia; Hypertriglyceridaemia
- Focus Pharmacokinetics
- 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Mar 2008 New trial record.